100-20 Recombinant Human VEGF165
產品名稱: 100-20 Recombinant Human VEGF165
英文名稱: 100-20 Recombinant Human VEGF165
產品編號: 100-20
產品價格: 0
產品產地: Peprotech
品牌商標: Peprotech
更新時間: null
使用范圍: null
- 聯系人 :
- 地址 : 北京市海淀區安寧莊西路15號
- 郵編 : 100080
- 所在區域 : 北京
- 電話 : 132****8551;153****6903 點擊查看
- 傳真 : 點擊查看
- 郵箱 : bio_fc@163.com
Recombinant Human VEGF165
細胞因子的作用特點:多效性、重疊性、協同性、拮抗性和雙重性。 細胞因子研究具有非常重要的理論和實用意義,它有助于闡明分子水平的免疫調節機理,有助于疾病的預防、診斷和治療,特別是利用基因工程技術生產的重組細胞因子已用于治療腫瘤、感染、炎癥、造血功能障礙等,并收到良好療效,具有非常廣闊的應用前景
|細胞因子|細胞培養|細胞|生長因子美國公司是全球最著名的重組細胞因子生廠商之一,目前已開發了350種以上的高品質重組細胞因子和相關抗體,依賴其獨有的E. Coli高效率表達系統使其產品的質量穩定,價格低,所有產品以凍干形式提供,以方便運輸和儲存,特別是以小包裝的細胞因子廣受全球客戶的青睞。產品主要包括免疫調節蛋白、白細胞介素、CSFs、生長因子、干擾素、Chemokines 、Adipokines 、TGF? / BMP Proteins、神經因子、FGFs和TNF配體/受體防御因子等。
?
?血管內皮生長因子(Vascular endothelial growth factor,VEGF)又稱血管通透因子(Vascular permeability factor,VPF),是胎兒和成人血管發生和血管生成過程中重要的調控因子。VEGF是特異性作用于內皮細胞的糖基化細胞有絲分裂素,在增強血管的滲透性、誘導血管發生和血管生成及內皮細胞生長、促進細胞遷移、抑制細胞凋亡等方面發揮作用。由于mRNA不同的剪切方式,產生了VEGF121、VEGF145、VEGF165、VEGF183、VEGF189和VEGF206等6種蛋白形式。VEGF165是人類組織中VEGF主要的基因產物,也是VEGF家族中最重要的血管生成調節因子。
Recombinant Human VEGF165
Maspin is a non-inhibitory member of the serpin superfamily, a group of 40-60 kDa serine protease inhibitors. Maspin was discovered in 1994 and has been identified in prostate, thymus, testis, intestine, tongue, and lung. Recently Maspin received a great deal of attention due to its potential apoptotic role in cancers. Maspin expression predicts a better prognosis for several types of carcinomas including breast, prostate, colon, and oral squamus cell carcinoma. The level of Maspin is also inversely correlated to VEGF-A, an angiogenic factor. Researchers found that Maspin may play its apoptotic role as an endogenous inhibitor of histone deacetylase I (HDAC I). Therefore, Maspin is a potential personalized marker of Non-Small Cell Lung Carcinoma (NSCLC).
Recombinant human Maspin (rhMaspin) produced in E. coli is a single non-glycosylated polypeptide chain containing 375 amino acids. rhMaspin has a molecular mass of 42.1 kDa analyzed by reducing SDS-PAGE and is obtained by chromatographic techniques at GenScript.
?
?
Recombinant Human VEGF165?
?
| 300-44 | Recombinant Human LEC/NCC-4(CCL16) | 5ug/20ug/ |
| 300-20 | Recombinant Human Lymphotactin(XCL1) | 5ug/20ug/ |
| 300-15 | Recombinant Human MCP-2(CCL8) | 2ug/10ug/ |
| 300-24 | Recombinant Human MCP-4(CCL13) | 5ug/20ug/ |
| 300-26 | Recombinant Human MIG(CXCL9) | 5ug/20ug/ |
| 300-29A | Recombinant Human MIP-3 a/CCL20 | 5ug/20ug/ |
| 300-34 | Recombinant Human MIP-4(CCL18) | 2ug/10ug/ |
| 300-43 | Recombinant Human MIP-5(CCL15) | 5ug/25ug/ |
| 300-14 | Recombinant Human NAP-2(CXCL7) | 5ug/20ug/ |
| 120-10 | Recombinant Human NOGGIN | 5ug/20ug/ |
| 300-10 | Recombinant Human Oncostatin M | 2ug/10ug/ |
| 650-14 | Recombinant Human Osteoprotegerin(OPG) | 10ug/50ug/ |
| 130-03 | Recombinant Human OTOR | 5ug/20ug/ |
| 130-13 | Recombinant PEDF | 5ug/20ug/ |
| 310-02 | Recombinant Human Scd40 Ligand | 10ug/50ug/ |
